[Hypersensitivity reactions caused by intravenously administered anticancer drugs]

Area of Science:

• Oncology
• Pharmacology
• Immunology

Context:

• Intravenous administration of cytotoxic drugs and biological antibodies is common in cancer therapy.
• Infusion reactions are a known complication, ranging from mild to life-threatening.
• Prompt and appropriate management is critical for patient safety.

Purpose:

• To review the management of infusion reactions associated with intravenous chemotherapy and antibody treatments.
• To highlight the critical role of adrenaline in managing severe reactions.
• To outline factors influencing the decision to re-challenge a patient with a previously causative agent.

Summary:

• Infusion reactions, while often mild, can be severe or fatal.
• Adrenaline is the primary treatment for severe infusion reactions.
• Decisions regarding re-administration of causative agents require a comprehensive assessment of reaction severity, mechanism, patient condition, cancer stage, and alternative treatment options.

Impact:

• Improved patient safety through optimized management of infusion reactions.
• Informed clinical decision-making regarding the re-challenge of patients with potentially causative agents.
• Enhanced understanding of risk-benefit assessment in cancer treatment protocols involving infusions.